Biotech pay analysis: 12 execs with $35M+ M&A golden parachutes

June 10, 2026 10:00 AM EDT DealsR&D Bio­phar­ma’s gold­en para­chutes: 12 ex­ecs who took in the biggest M&A wind­falls of $35M+ Andrew Dunn Senior Biopharma Correspondent A dozen biotech ex­ec­u­tives took home near­ly $1 bil­lion worth of ex­it pack­ages from sell­ing their com­pa­nies, an End­points News analy­sis found. The drug in­dus­try … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER